These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25111898)

  • 1. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
    Ali A; Shah AS; Ahmad A
    Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
    Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
    J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
    Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
    Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis.
    Zhou S; Tang X; Tang F
    Tumour Biol; 2016 Feb; 37(2):1505-13. PubMed ID: 26662959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11.
    Noll JE; Jeffery J; Al-Ejeh F; Kumar R; Khanna KK; Callen DF; Neilsen PM
    Oncogene; 2012 Jun; 31(23):2836-48. PubMed ID: 21986947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.
    Li S; Qin X; Cui A; Wu W; Ren L; Wang X
    Int J Clin Exp Pathol; 2015; 8(9):11157-63. PubMed ID: 26617836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.
    Neilsen PM; Noll JE; Mattiske S; Bracken CP; Gregory PA; Schulz RB; Lim SP; Kumar R; Suetani RJ; Goodall GJ; Callen DF
    Oncogene; 2013 Jun; 32(24):2992-3000. PubMed ID: 22797073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
    Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
    PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.
    Cai XD; Che L; Lin JX; Huang S; Li J; Liu XY; Pan XF; Wang QQ; Chen L; Lin MJ; Huang ZH; Ma HM; Wu Y; Liu SM; Zhou YB
    Oncotarget; 2017 Jun; 8(24):38743-38754. PubMed ID: 28454121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.
    Gumireddy K; Li A; Gimotty PA; Klein-Szanto AJ; Showe LC; Katsaros D; Coukos G; Zhang L; Huang Q
    Nat Cell Biol; 2009 Nov; 11(11):1297-304. PubMed ID: 19801974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells.
    Kim TH; Lee SY; Rho JH; Jeong NY; Soung YH; Jo WS; Kang DY; Kim SH; Yoo YH
    Mol Cancer Res; 2009 Oct; 7(10):1645-54. PubMed ID: 19825993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
    Ye WC; Gao L; Huang J; Fang XM; Xie G
    Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression.
    Ismail IA; Kang HS; Lee HJ; Kim JK; Hong SH
    Br J Cancer; 2014 Mar; 110(5):1298-306. PubMed ID: 24504364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
    D'Assoro AB; Leontovich A; Amato A; Ayers-Ringler JR; Quatraro C; Hafner K; Jenkins RB; Libra M; Ingle J; Stivala F; Galanis E; Salisbury JL
    Int J Oncol; 2010 Nov; 37(5):1167-76. PubMed ID: 20878064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.